TTFields
TTFields have been approved by FDA for the treatment of adult patients suffering from newly diagnosed and recurrent glioblastoma.
TTFields is currently being tested for other cancers in various clinical trials, presented in this website. TTFields is experimental for all indications mentioned in those clinical trials and has not been approved for their treatment.